Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension

American Journal of Respiratory and Critical Care Medicine, 2026

Osterhout R., Boucly A., Benza R., Channick R., Chin K., Frantz R., Hemnes A., Howard L., Mclaughlin V., Sitbon O., Vachiéry J., Zamanian R., Aranda R., Cravets M., Ding Z., Duong-Verlé T., Mottola D., Roscigno R., Sitapara R., Zisman L., Bruey J., Ghofrani H.